BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

905 related articles for article (PubMed ID: 17374087)

  • 1. Cardiovascular calcification in nondialyzed patients with chronic kidney disease.
    Qunibi WY
    Semin Dial; 2007; 20(2):134-8. PubMed ID: 17374087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disordered mineral metabolism and vascular calcification in nondialyzed chronic kidney disease patients.
    Mehrotra R
    J Ren Nutr; 2006 Apr; 16(2):100-18. PubMed ID: 16567266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and associations of coronary artery calcification in patients with stages 3 to 5 CKD without cardiovascular disease.
    Garland JS; Holden RM; Groome PA; Lam M; Nolan RL; Morton AR; Pickett W
    Am J Kidney Dis; 2008 Nov; 52(5):849-58. PubMed ID: 18562059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing the burden of cardiovascular calcification in patients with chronic kidney disease.
    Qunibi WY
    J Am Soc Nephrol; 2005 Nov; 16 Suppl 2():S95-102. PubMed ID: 16251249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular calcification in chronic kidney disease: pathogenesis and clinical implications.
    Shioi A; Nishizawa Y
    J Ren Nutr; 2009 Jan; 19(1):78-81. PubMed ID: 19121777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recent advances in the prevention of cardiovascular morbidity and mortality in end-stage renal disease: role of anemia, hyperparathyroidism and calcifications].
    Del Vecchio L; Pozzoni P; Limardo M; Caruso S; Fortunato M; Pontoriero G; Locatelli F
    G Ital Nefrol; 2007; 24 Suppl 38():25-32. PubMed ID: 17922444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mineral metabolism disturbances in patients with chronic kidney disease.
    Kestenbaum B; Belozeroff V
    Eur J Clin Invest; 2007 Aug; 37(8):607-22. PubMed ID: 17635571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How long is the warranty period for nil or low coronary artery calcium in patients new to hemodialysis?
    Bellasi A; Kooienga L; Block GA; Veledar E; Spiegel DM; Raggi P
    J Nephrol; 2009; 22(2):255-62. PubMed ID: 19384844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cut-off value of plasma osteoprotegerin level may predict the presence of coronary artery calcifications in chronic kidney disease patients.
    Morena M; Dupuy AM; Jaussent I; Vernhet H; Gahide G; Klouche K; Bargnoux AS; Delcourt C; Canaud B; Cristol JP
    Nephrol Dial Transplant; 2009 Nov; 24(11):3389-97. PubMed ID: 19574342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Why do patients with kidney diseases end up with a heart of stone? Disturbances in calcium-phosphate balance and chronic inflammation important causes].
    Martola L; Elinder CG; Stenvinkel P
    Lakartidningen; 2003 Dec; 100(50):4180-3. PubMed ID: 14717005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy for the altered mineral metabolism of chronic kidney disease: implications for vascular calcification.
    Saab G; Whaley-Connell AT; Khanna R; Sowers JR
    Ther Adv Cardiovasc Dis; 2007 Dec; 1(2):107-12. PubMed ID: 19124399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Arteriosclerosis and vascular calcification in chronic kidney disease (CKD) patients].
    Masho Y; Shigematsu T
    Clin Calcium; 2007 Mar; 17(3):354-9. PubMed ID: 17339739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valvular calcification and its relationship to atherosclerosis in chronic kidney disease.
    Leskinen Y; Paana T; Saha H; Groundstroem K; Lehtimäki T; Kilpinen S; Huhtala H; Airaksinen J
    J Heart Valve Dis; 2009 Jul; 18(4):429-38. PubMed ID: 19852148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins and cardiovascular risk reduction in patients with chronic kidney disease and end-stage renal failure.
    Baber U; Toto RD; de Lemos JA
    Am Heart J; 2007 Apr; 153(4):471-7. PubMed ID: 17383281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of coronary artery calcification score (CACS) for the detection of coronary artery disease (CAD) in chronic dialysis patients.
    Fujimoto N; Iseki K; Tokuyama K; Tamashiro M; Takishita S
    Clin Chim Acta; 2006 May; 367(1-2):98-102. PubMed ID: 16413522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Animal models--what they can tell us about vascular calcification in CKD.
    Massy ZA; Slama M; Tribouilloy C; Drüeke TB
    Semin Dial; 2007; 20(2):110-2. PubMed ID: 17374083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphate metabolism in the setting of chronic kidney disease: significance and recommendations for treatment.
    Kestenbaum B
    Semin Dial; 2007; 20(4):286-94. PubMed ID: 17635817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different risk factors for vascular calcification in end-stage renal disease between diabetics and nondiabetics: the respective importance of glycemic and phosphate control.
    Ishimura E; Okuno S; Taniwaki H; Kizu A; Tsuchida T; Shioi A; Shoji T; Tabata T; Inaba M; Nishizawa Y
    Kidney Blood Press Res; 2008; 31(1):10-5. PubMed ID: 18097148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The renal patient with cardiovascular disease--no longer a simple plumbing problem.
    Tunuguntla A; Yerra L
    Tenn Med; 2005 Aug; 98(8):395-6, 399. PubMed ID: 16315466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary calcification is associated with lower bone formation rate in CKD patients not yet in dialysis treatment.
    Tomiyama C; Carvalho AB; Higa A; Jorgetti V; Draibe SA; Canziani ME
    J Bone Miner Res; 2010 Mar; 25(3):499-504. PubMed ID: 19594321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.